// App-Quantinova.ai

POS01 : Impact of a 24- rather than 6-month dual antiplatelet therapy with clopidogrel in patients with left main or proximal left anterior descending coronary artery disease. A post hoc analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent Induced Intimal Hyperplasia) PRODIGY trial

Researchers

Presenter

  • Costa F

Principal Investigators

  • Ariotti S

  • Oreto G

  • Ando G

  • Valgimigli M

Medical Centers

  • Policlinico Universitario G Martino, Messina, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Intimal hyperplasia

  • Restenosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved